Denise Zou
Denise Zou publishes mostly in Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine, on topics such as Economic and Financial Impacts of Cancer, Cancer Genomics and Diagnostics and Lymphoma Diagnosis and Treatment.
- World rank
- #3,372,015 of 7,710,434 ranked researchers
- Rank in United States
- #949,614 of 1,627,098
- Works
- 32
- Citations
- 136
- Citations per work
- 4.3
What does Denise Zou research?
Denise Zou's work is mostly in Medicine (52%), Economics, Econometrics and Finance (19%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1751.6%
- Medicine1751.6%
- Everything else720.5%
- Social Sciences619.1%
- Life Sciences38.8%
- 1Oncology25% of their works
- 2Economics and Econometrics19% of their works
- 3Pulmonary and Respiratory Medicine12% of their works
- 4Cancer Research9% of their works
- 5Hematology7% of their works
- 6Pathology and Forensic Medicine7% of their works
Research topics
- Economic and Financial Impacts of Cancer
- Cancer Genomics and Diagnostics
- Lymphoma Diagnosis and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Colorectal Cancer Screening and Detection
- Lung Cancer Treatments and Mutations
- Chronic Myeloid Leukemia Treatments
- Global Cancer Incidence and Screening
Which keywords describe Denise Zou's research?
The keywords of their largest research topics: Targeted Therapy, Cost of Care, Financial Toxicity, Risk Factors, Cancer Genomics, Classification, Cost-effectiveness Analysis and Lymphoma.
- Mortality Rates
- Cancer Incidence
- Screening
- Colorectal Cancer
- Quality of Life
- Lymphoma
- Classification
- Risk Factors
- Cost of Care
- Targeted Therapy
- Financial Toxicity
- Cancer Genomics
- Cost-effectiveness Analysis
- Mutational Signatures
- ALK Inhibitors
- EGFR Mutations
- BCR-ABL
- Imatinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Targeted Therapy92 topics
- Cost of Care71 topic
- Financial Toxicity71 topic
- Risk Factors72 topics
- Cancer Genomics51 topic
- Classification51 topic
- Cost-effectiveness Analysis51 topic
- Lymphoma51 topic
- Mutational Signatures51 topic
- Quality of Life51 topic
- ALK Inhibitors41 topic
- Colorectal Cancer41 topic
- EGFR Mutations41 topic
- Screening41 topic
- BCR-ABL31 topic
- Cancer Incidence31 topic
- Imatinib31 topic
- Mortality Rates31 topic
Where does Denise Zou work?
Denise Zou's main affiliation in the publication record is Ithaka Harbors, United States.
How many publications and citations does Denise Zou have?
OpenAlex counts 32 works and 136 citations for Denise Zou, an h-index of 5, ranking #3,372,015 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Denise Zou. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.